Akihiko Ueda

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda et al. · Journal of Clinical Oncology · 2015 · 1.2K citations

CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer

Masayo Ukita, Junzo Hamanishi, Hiroyuki Yoshitomi et al. · JCI Insight · 2022 · 172 citations · Full text

Lymphoid Neoplasia, Cancer Immunosurveillance, T-regulatory Cell +12

Efficacy and safety of anti-PD-1 antibody (Nivolumab: BMS-936558, ONO-4538) in patients with platinum-resistant ovarian cancer.

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda et al. · Journal of Clinical Oncology · 2014 · 60 citations

Cancer Management, Immunology, Gynecology +19

Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014

Akihiko Ueda, Mitsuharu Ueda, Akihito Nagatoshi et al. · Journal of Neurology · 2015 · 58 citations

Referral Center, Genetics, Kumamoto University +4

Sporadic juvenile amyotrophic lateral sclerosis caused by mutant FUS/TLS: possible association of mental retardation with this mutation

Satoshi Yamashita, Akira Mori, Hideya Sakaguchi et al. · Journal of Neurology · 2011 · 52 citations

Mutant Fus/tls, Amyotrophic Lateral Sclerosis, Mendelian Disorder +11